TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Waters Corporation (WAT)

Healthcare Diagnostics & Research
377.20 $
-0.8% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Waters Corporation.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 2 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
380.30$
Open
383.80$
Day High
385.00$
Day Low
370.80$
Volume
714,724shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
277.70 $ 412.50 $
08/06/2025 11/25/2025

Current price 377.20 $ — 74% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
37.0$B
Shares Outstanding
98Mio.
Float
99.8%
Beta
1.2

Performance

Perf. 1M
0.60%
Perf. 3M
27.60%
Perf. 6M
-4.10%
YTD Performance (%)
-6.00%
52-Week-High Distance
-9.0%
Perf. 1Y
30.67%
Perf. 3Y
36.60%
Perf. 5Y
-3.21%
Perf. 10Y
137.41%
Perf. Since Inception
9,935.91%

Technical Indicators

MA 38 Days
370.40$
MA 50 Days
368.00$
MA 200 Days
354.40$
RSI (14)
53.4
Volatility 30 Days
27.4%
Volatility 250 Days
36.4%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
47.7
Forward P/E
26.4
PEG
1.7
P/B
2.4
P/S
9.8
EV/EBITDA
42.6
Price/FCF
140.3

Profitability

Gross Margin
55.2%
EBIT Margin
2.8%
Net Margin
11.9%
Return on Equity
5.2%
Return on Assets
3.3%

Balance Sheet & Safety

Equity Ratio
62.3%
Debt/Equity
0.9
fortress balance sheet
Altman Z″
7.01
weak
Piotroski
2 out of 9

Growth

Sales Growth Last Quarter
91.40%
EPS Growth Last Quarter
-3.10%
Sales Growth (Year)
6.99%
Forward Sales Growth
10.42%
Forward EPS Growth
13.40%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
3
RS Rating
49
EPS Rating
30
weak
Piotroski
2 out of 9
Fundamental Rating
C (50 out of 100)
fortress balance sheet
Altman Z″
7.01

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 377.20 $
Price Target (average) 413.26 $

The price target sits 9.6% above the current price.

Consensus
Sell
Analyst Ratings
22
Distribution of Recommendations
Strong Buy 6
Buy 1
Hold 15
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 14.51 14.44 – 14.63 6,442 10.5% 24
12/31/2027 16.49 15.85 – 17.57 7,111 13.6% 24

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

4. Aug 2026 · before the open · Q2 2026
Expected Earnings per Share
3.01 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 872.7 $M Q4 2025: Q1 · 661.7 $M Q1 2025: Q2 · 771.3 $M Q2 2025: Q3 · 799.9 $M Q3 2025: Q4 · 932.4 $M Q4 2026: Q1 · 1,267.0 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 3.88 6.40 873 6.50 26.50 240 188
2025: Q1 2.03 18.20 662 3.90 18.30 260 234
2025: Q2 2.47 2.70 771 8.90 19.10 41 19
2025: Q3 2.50 -8.00 800 8.00 18.60 187 162
2025: Q4 3.77 -2.90 932 6.80 24.20 165 126
2026: Q1 -0.88 -143.10 1,267 91.50 -5.70 -3 -42
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 2,167 625 522 6.41 629 2,302 4,662
2017 2,309 662 20 0.25 698 2,234 5,339
2018 2,420 740 594 7.65 604 1,567 3,727
2019 2,407 708 592 8.69 643 -216 2,557
2020 2,365 645 522 8.36 791 232 2,840
2021 2,786 822 693 11.17 747 368 3,095
2022 2,972 873 708 11.73 612 504 3,281
2023 2,956 818 642 10.84 603 1,150 4,627
2024 2,958 826 638 10.71 762 1,829 4,554
2025 3,165 893 643 10.76 653 2,561 5,077

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Waters Corporation bietet analytische Workflow-Lösungen in Asien, Nord- und Südamerika und Europa an. Das Unternehmen ist in zwei Segmenten tätig: Waters und TA.

Employees16,000
HeadquartersMilford, MA
Address34 Maple Street, 01757 Milford, United States
Phone508 478 2000
Websitewaters.com
IPO Date16. Nov 1995
ISINUS9418481035
Stock Split2:1 on 08/28/2000

Management

Management
Name Title Birth Year
Udit Batra Ph.D. President, CEO & Director 1971
Amol Chaubal Senior VP & CFO 1977
Jianqing Y. Bennett Senior Vice President of Waters Advanced Diagnostics 1970
Robert L. Carpio III Senior Vice President of Waters Analytical Sciences 1983
Christos Ross Senior Vice President of Global Operations
Brook M. Colangelo Senior VP & Chief Information Officer 1978
Caspar Tudor Head of Investor Relations
Keeley A. Aleman J.D. Senior VP, General Counsel & Head of Global Human Resources 1977
Kristen Garvey Senior Vice President of Global Communications
Daniel Rush Ph.D. Senior Vice President of Global Research & Strategy

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?